Intensity Therapeutics, Inc. Stock: price and insider trades · United States
Intensity Therapeutics, Inc.: what insiders have been doing
Every trade that managers of Intensity Therapeutics, Inc. disclose to SEC (Form 4) is tracked on this page. The last twelve months, up to 8 November 2026, brought 3 filings signed by 3 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 5,808 companies) published 19 filings over the same period, against 3 filings here. For the fiscal year to 31 December 2025, the annual 10-K puts net income at -11.6 m USD.
Over the last twelve months, not one insider purchase of Intensity Therapeutics, Inc. stock was filed. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 37,749 shares@ US$6.11100.0% of flowCommon Stock, $0.0001 Par ValueSEC:0001238705-26-000005:0
- 8,918 shares@ US$0.2629.4% of flowCommon Stock, $0.0001 Par ValueSEC:0001895944-26-000003:0
- 14,482 shares@ US$0.26250.7% of flowCommon Stock, $0.0001 Par ValueSEC:0001524547-26-000003:0
- 69,745 shares@ US$0.26173.2% of flowCommon Stock, $0.0001 Par ValueSEC:0001567264-25-000066:0
- 14,179 shares@ US$0.26149.3% of flowCommon Stock, $0.0001 Par ValueSEC:0001567264-25-000065:0
- 1,000 shares@ US$4.0017.4% of flowCommon Stock, $0.0001 Par ValueSEC:0001895944-24-000011:0
6 of 6 declarations
About Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative cancer treatments. It is listed on the NASDAQ under the ticker symbol INTZ.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
